Terms: = Brain cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31 AND Treatment
11 results:
1. Proton Therapy Mediates Dose Reductions to brain Structures Associated With Cognition in Children With Medulloblastoma.
Sienna J; Kahalley LS; Mabbott D; Grosshans D; Santiago AT; Paulino ADC; Merchant TE; Manzar GS; Dama H; Hodgson DC; Chintagumpala M; Okcu MF; Whitehead WE; Laperriere N; Ramaswamy V; Bartels U; Tabori U; Bennett JM; Das A; Craig T; Tsang DS
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):200-207. PubMed ID: 38040059
[TBL] [Abstract] [Full Text] [Related]
2. Identification and characterization of sex-dependent gene expression profile in glioblastoma.
Qin S; Yuan Y; Liu H; Pu Y; Chen K; Wu Y; Su Z
Neuropathology; 2023 Feb; 43(1):72-83. PubMed ID: 35789505
[TBL] [Abstract] [Full Text] [Related]
3. The Capabilities and Characteristics of Helical Tomotherapy and Co-Planar Dual Arcs Volumetric-Modulated arc Therapy Associated with Hippocampal Sparing During Prophylactic Cranial Irradiation.
Wang D; Ma X; Fu L; Gu J; Bai T; Yin Y; Li B; Zhu J
Technol Cancer Res Treat; 2021; 20():15330338211043975. PubMed ID: 34632869
[No Abstract] [Full Text] [Related]
4. Hippocampal sparing in patients receiving radiosurgery for ≥25 brain metastases.
Kavi A; Gurewitz J; Benjamin CG; Silverman JS; Bernstein K; Mureb M; Oh C; Sulman EP; Donahue B; Kondziolka D
Radiother Oncol; 2021 Aug; 161():65-71. PubMed ID: 34052342
[TBL] [Abstract] [Full Text] [Related]
5. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract] [Full Text] [Related]
6. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole brain Radiation Therapy for Patients With 10 to 30 brain Metastases: A Dosimetric Analysis.
Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
[TBL] [Abstract] [Full Text] [Related]
7. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
[TBL] [Abstract] [Full Text] [Related]
8. Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs.
Martin F; Magnier F; Berger L; Miroir J; Chautard E; Verrelle P; Lapeyre M; Biau J
Radiat Oncol; 2016 Apr; 11():58. PubMed ID: 27090091
[TBL] [Abstract] [Full Text] [Related]
9. brain-sparing methods for IMRT of head and neck cancer.
Dunlop A; Welsh L; McQuaid D; Dean J; Gulliford S; Hansen V; Bhide S; Nutting C; Harrington K; Newbold K
PLoS One; 2015; 10(3):e0120141. PubMed ID: 25781636
[TBL] [Abstract] [Full Text] [Related]
10. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract] [Full Text] [Related]
11. Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme.
Ali AN; Ogunleye T; Hardy CW; Shu HK; Curran WJ; Crocker IR
Radiat Oncol; 2014 Jan; 9():20. PubMed ID: 24411020
[TBL] [Abstract] [Full Text] [Related]
